Search

everythinglearnresearchcommunity

for

Search:↓

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

Certain medications can cause gum problems, so patients and healthcare providers should be aware and monitor oral health.

The skin microbiome is crucial for skin health and new treatments like probiotics can improve skin conditions.

Women with PCOS have more severe liver disease.

Certain gene variants can influence acne risk and severity.

Red and near-infrared light-emitting fabric may help improve psoriasis, PMLE, and alopecia areata.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Trichoscopy effectively diagnoses and monitors treatment in children with tinea capitis.

PCOS causes sexual dysfunction, needing comprehensive treatment.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Epigenetic changes in skin cells contribute to aging, but targeting these changes may offer new antiaging treatments.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Low PON1 levels may indicate and predict the severity of hair loss.

More effective treatments are needed for severe alopecia areata.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Hair manganese may relate to cardiometabolic health, not coronary artery disease severity.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

Oxidative stress may worsen female pattern hair loss and could help track the disease and treatment.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Trichoscopy is better than the hair pull test for tracking alopecia areata.

Finasteride may cause depression and suicidal thoughts, especially in young men.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Ongoing monitoring and treatment are crucial to manage sarcoptic mange in reintroduced red foxes.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.